Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial

E Malek, J Kort, L Metheny, P Fu, G Li, P Hari… - … and Cellular Therapy, 2024 - Elsevier
Obesity is a common health problem in patients with multiple myeloma (MM) that has been
linked to poor clinical outcomes and quality of life (QoL). We conducted a secondary …
相关文章

Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial

E Malek, J Kort, L Metheny, P Fu, P Hari… - Research …, 2023 - pubmed.ncbi.nlm.nih.gov
Obesity is a common health problem among multiple myeloma (MM) patients, and it has
been linked to poor clinical outcomes and quality of life (QOL). We conducted a secondary …
[HTML] nih.gov

[HTML][HTML] Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702 …

E Malek, J Kort, L Metheny, P Fu, P Hari, G Li… - Research … - ncbi.nlm.nih.gov
Obesity is a common health problem among multiple myeloma (MM) patients, and it has
been linked to poor clinical outcomes and quality of life (QOL). We conducted a secondary …

Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial

E Malek, J Kort, L Metheny, P Fu… - Transplantation …, 2024 - mdanderson.elsevierpure.com
Obesity is a common health problem in patients with multiple myeloma (MM) that has been
linked to poor clinical outcomes and quality of life (QoL). We conducted a secondary …

Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial.

E Malek, J Kort, L Metheny, P Fu, P Hari, G Li… - Research …, 2023 - europepmc.org
Obesity is a common health problem among multiple myeloma (MM) patients, and it has
been linked to poor clinical outcomes and quality of life (QOL). We conducted a secondary …

Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial

E Malek, J Kort, L Metheny, P Fu, P Hari, G Li… - 2023 - researchsquare.com
Obesity is a common health problem among multiple myeloma (MM) patients, and it has
been linked to poor clinical outcomes and quality of life (QOL). We conducted a secondary …

Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial

E Malek, J Kort, L Metheny, P Fu, G Li, P Hari… - … and Cellular Therapy … - astctjournal.org
Obesity is a common health problem in patients with multiple myeloma (MM) that has been
linked to poor clinical outcomes and quality of life (QoL). We conducted a secondary …

Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial

E Malek, J Kort, L Metheny, P Fu, G Li… - … and cellular therapy - pubmed.ncbi.nlm.nih.gov
Obesity is a common health problem in patients with multiple myeloma (MM) that has been
linked to poor clinical outcomes and quality of life (QoL). We conducted a secondary …

Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial.

E Malek, J Kort, L Metheny, P Fu, G Li… - … and Cellular Therapy, 2024 - europepmc.org
Obesity is a common health problem among multiple myeloma (MM) patients, and it has
been linked to poor clinical outcomes and quality of life (QOL). We conducted a secondary …